1. Ikeda Y, Adachi K, Tomio K, Eguchi-Kojima S, Tsuruga T, Uchino-Mori M, Taguchi A, Komatsu A, Nagamatsu T, Kawana-Tachikawa A, Uemura Y, Igimi S, Osuga Y, Fujii T, and Kawana K. A placebo-controlled double-blind randomized (Phase IIB) trial of oral administration with HPV16 E7-expressing Lactobacillus, GLBL101c, for treatment of cervical intraepithelial neoplasia grade 2 (CIN2). Vaccines. 2021, 9(4), 329; doi.org/10.3390/vaccines9040329
2. Kawana K, Kobayashi O, Nakajima T, Nakao T, Ikeda Y, Asai-Sato M, Chishima F, Novel Approach for Therapeutics of Cervical Cancer Based on HPV-Associated Carcinogenesis at the Cervix, Current Human Cell Research and Applications Vol. 5, Seiji Isonishi and Yoshihiro Kikuchi (Eds): Molecular Diagnosis and Targeting for Gynecologic Malignancy, 978-981-33-6012-9, 493109_1_En, (Chapter 11), 133-144, Springer Nature, 2021
3. Kawata A, Taguchi A, Baba S, Miyamoto Y , Tanikawa M , Sone K , Tsuruga T, Mori M ,Oda K,Kawana K ,Osuga Y , Fujii, T . A low preoperative albumin-to-globulin ratio is a negative prognostic factor in patients with surgically treated cervical cancer . Int J Clin Oncol. 2021 Jan 21. doi: 10.1007/s10147-021-01861-8.
4. Taguchi A, Nagasaka K, Plessy C, Nakamura H, Kawata Y, Kato S, Hashimoto K, Nagamatsu T, Oda K, Kukimoto I, Kawana K, Carninci P, Osuga Y, Fujii T, Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stages. Sci Rep. 10: 17991., 2020 doi: 10.1038/s41598-020-75133-2.
5. Taguchi A, Hara K, Tomio J, Kawana K, Tanaka T, Baba S, Kawata A, Eguchi S, Tsuruga T, Mori M, Adachi K, Nagamatsu T, Oda K, Yasugi T, Osuga Y, Fujii T, Multistate Markov model to predict the prognosis of high-risk human papillomavirus-related cervical lesions, Cancers, 12(2): E270, 2020, doi: 10.3390/cancers12020270.
6. Baba S, Taguchi A, Kawata A, Hara K, Eguchi S, Mori M, Adachi K, Mori S, Iwata T, Mitsuhashi A, Maeda D, Komatsu A, Nagamatsu T,Oda K,Kukimoto I, Osuga Y, Fujii T, Kawana K.Differential expression of human papilloma virus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia, Virol J, 17: 32, 2020.doi: 10.1186/s12985-020-01306-0, 2020
7. 川名 敬、1章 子宮頸癌 分子生物学の進歩、悪性腫瘍(産科婦人科腫瘍 5)、3-9、中山出版
8. 川名 敬、ヒトパピローマウイルス感染症、52増刊号,1143-1148、小児内科
9. 川名 敬、周産期医学 必須知識第9版 合併症妊娠 子宮頸癌合併妊、51、増刊号、116-119
10. 川名 敬、ヒトパピローマウイルス(HPV)ワクチン、1919-1920今日の治療指針、医学書院